Stem Cell

Cryo-Save Group Launches in India

It has set up a state-of-the-art, fully automated stem cell banking facility at Bangalore

VR Chandramouli

Cryo-Save Group announced the launch of its India operations through its 100 per cent subsidiary Cryo-Save India. The Indian subsidiary has been set up with an investment of 1.8 million Euros.

Cryo-Save Group will scale-up its investment to two million Euros within a year of its operation of the Indian subsidiary. Cryo-Save India is headquartered in Bangalore with a state-of-the art fully automated adult stem-cell storage facility. The facility at Bangalore covers 10,000 square feet with a storage capacity of 1,50,000 samples extendable to 3,00,000.

Cryo-Save Group, Europe's largest adult stem-cell storage bank, has its operations in 37 countries across three continents. Said VR Chandramouli, Managing Director, Cryo-Save India, "We are very happy to launch the Indian subsidiary and offer our expertise in adult stem-cell banking services in India. A world class stem cell banking service was the need of the hour for a huge market like India and Cryo-Save India will be offering this. We are very keen to extend our footprints to India and we are very excited about the immense market potential for adult stem cell banking or family banking in India. The launch of the Indian operations will mark a new chapter in the quality of stem cell banking services offered. Cryo-Save India will bring in our global expertise, best practices and our vast experience to the Indian customer."

"Cryo-Save India will be the only company in India with its unique offering of dual-storage system and this will be available for the first time in the country. They are also the only company that does automatic processing to avoid manual intervention and contamination. The company will be offering the collection and storage of adult stem cells derived from cord blood. The services will be available across all metros and other cities," he added.

"We see a huge potential in the stem cell banking business in India and we have set-up the best-in-class facility with an investment of nearly 1.8 million Euros to cater to this huge need which is set to grow manifold," he further added.

Stem cells are the natural repair kit of the human body. "In the last 18 years more than 10,000 patients have been treated with cord blood stem-cells transplantations in over 150 countries," he said. Umbilical cord blood stem cells have been used over the years in an increasing number of treatments including leukemia, myelodysplastic syndrome, lymphomas, red cell disorders and more. Currently, stem cell research is being done for more than 85 diseases.

EH News Bureau